Your browser doesn't support javascript.
loading
Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium.
Scott, Gregory D; Arnold, Moriah R; Beach, Thomas G; Gibbons, Christopher H; Kanthasamy, Anumantha G; Lebovitz, Russell M; Lemstra, Afina W; Shaw, Leslie M; Teunissen, Charlotte E; Zetterberg, Henrik; Taylor, Angela S; Graham, Todd C; Boeve, Bradley F; Gomperts, Stephen N; Graff-Radford, Neill R; Moussa, Charbel; Poston, Kathleen L; Rosenthal, Liana S; Sabbagh, Marwan N; Walsh, Ryan R; Weber, Miriam T; Armstrong, Melissa J; Bang, Jee A; Bozoki, Andrea C; Domoto-Reilly, Kimiko; Duda, John E; Fleisher, Jori E; Galasko, Douglas R; Galvin, James E; Goldman, Jennifer G; Holden, Samantha K; Honig, Lawrence S; Huddleston, Daniel E; Leverenz, James B; Litvan, Irene; Manning, Carol A; Marder, Karen S; Pantelyat, Alexander Y; Pelak, Victoria S; Scharre, Douglas W; Sha, Sharon J; Shill, Holly A; Mari, Zoltan; Quinn, Joseph F; Irwin, David J.
Afiliación
  • Scott GD; Department of Pathology, Oregon Health and Science University, Portland, OR, United States.
  • Arnold MR; Department of Pathology and Laboratory Services, VA Portland Medical Center, Portland, OR, United States.
  • Beach TG; Graduate Program in Biomedical Sciences, School of Medicine M.D./Ph.D. Program, Oregon Health and Science University, Portland, OR, United States.
  • Gibbons CH; Civin Laboratory for Neuropathology and Brain and Body Donation Program, Banner Sun Health Research Institute, Sun City, AZ, United States.
  • Kanthasamy AG; Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States.
  • Lebovitz RM; Department of Physiology and Pharmacology, Center for Brain Sciences and Neurodegenerative Diseases, University of Georgia, Athens, GA, United States.
  • Lemstra AW; Amprion Inc., San Francisco, CA, United States.
  • Shaw LM; Department of Neurology, Amsterdam University Medical Center (UMC), Alzheimer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
  • Teunissen CE; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Zetterberg H; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
  • Taylor AS; Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
  • Graham TC; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
  • Boeve BF; Department of Neurodegenerative Disease, University College London (UCL) Institute of Neurology, London, United Kingdom.
  • Gomperts SN; UK Dementia Research Institute at University College London, London, United Kingdom.
  • Graff-Radford NR; Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.
  • Moussa C; Lewy Body Dementia Association, Lilburn, GA, United States.
  • Poston KL; Lewy Body Dementia Association, Lilburn, GA, United States.
  • Rosenthal LS; Department of Neurology and Center for Sleep Medicine, Mayo Clinic, Rochester, MN, United States.
  • Sabbagh MN; Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.
  • Walsh RR; Department of Neurology, Mayo Clinic, Jacksonville, FL, United States.
  • Weber MT; Department of Neurology, Georgetown University Medical Center, Washington DC, CA, United States.
  • Armstrong MJ; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, United States.
  • Bang JA; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, United States.
  • Bozoki AC; Department of Neurology, Barrow Neurological Institute, Phoenix, AZ, United States.
  • Domoto-Reilly K; Barrow Neurological Institute and Muhammed Ali Parkinson Center, Phoenix, AZ, United States.
  • Duda JE; Department of Neurology, University of Rochester, Rochester, NY, United States.
  • Fleisher JE; Department of Neurology, University of Florida College of Medicine, Gainesville, FL, United States.
  • Galasko DR; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Galvin JE; Department of Neurology, University of North Carolina, Chapel Hill, NC, United States.
  • Goldman JG; Department of Neurology, University of Washington, Seattle, WA, United States.
  • Holden SK; Parkinson's Disease Research, Education and Clinical Center, Michael J. Crescenz VA Medical Center, Philadelphia, PA, United States.
  • Honig LS; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Huddleston DE; Department of Neurological Sciences, Rush Medical College, Chicago, IL, United States.
  • Leverenz JB; Department of Neurosciences, University of California, San Diego, San Diego, CA, United States.
  • Litvan I; Department of Neurology, Comprehensive Center for Brain Health, University of Miami Miller School of Medicine, Miami, FL, United States.
  • Manning CA; Shirley Ryan Abilitylab and Department of Physical Medicine and Rehabilitation and Neurology, Parkinson's Disease and Movement Disorders, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
  • Marder KS; Department of Neurology, University of Colorado School of Medicine, Aurora, CO, United States.
  • Pantelyat AY; Columbia University Irving Medical Center, New York, NY, United States.
  • Pelak VS; Department of Neurology, Emory University School of Medicine, Atlanta, GA, United States.
  • Scharre DW; Lou Ruvo Center for Brain Health, Cleveland Clinic, Cleveland, OH, United States.
  • Sha SJ; Department of Neurosciences, University of California, San Diego, San Diego, CA, United States.
  • Shill HA; Department of Neurology, University of Virginia, Charlottesville, VA, United States.
  • Mari Z; Columbia University Irving Medical Center, New York, NY, United States.
  • Quinn JF; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Irwin DJ; Departments of Neurology and Ophthalmology, University of Colorado School of Medicine, Aurora, CO, United States.
Front Neurol ; 12: 805135, 2021.
Article en En | MEDLINE | ID: mdl-35173668
ABSTRACT
The Lewy Body Dementia Association (LBDA) held a virtual event, the LBDA Biofluid/Tissue Biomarker Symposium, on January 25, 2021, to present advances in biomarkers for Lewy body dementia (LBD), which includes dementia with Lewy bodies (DLBs) and Parkinson's disease dementia (PDD). The meeting featured eight internationally known scientists from Europe and the United States and attracted over 200 scientists and physicians from academic centers, the National Institutes of Health, and the pharmaceutical industry. Methods for confirming and quantifying the presence of Lewy body and Alzheimer's pathology and novel biomarkers were discussed.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Neurol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Neurol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos